CN Stock MarketDetailed Quotes

688166 Brightgene Bio-Medical Technology Co.,Ltd.

Watchlist
  • 25.00
  • -0.19-0.75%
Market Closed Aug 23 15:00 CST
10.56BMarket Cap52.97P/E (TTM)

Brightgene Bio-Medical Technology Co.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
11.95%657.69M
11.54%340.13M
15.94%1.18B
18.46%914.88M
17.41%587.48M
22.77%304.94M
-3.33%1.02B
3.19%772.32M
4.43%500.35M
31.53%248.37M
Operating revenue
11.95%657.69M
11.54%340.13M
15.94%1.18B
18.46%914.88M
17.41%587.48M
22.77%304.94M
-3.33%1.02B
3.19%772.32M
4.43%500.35M
31.53%248.37M
Total operating cost
19.72%554.21M
16.64%267.34M
25.15%980.32M
23.89%699.6M
20.45%462.93M
26.32%229.2M
-0.78%783.33M
4.30%564.69M
8.62%384.34M
35.63%181.44M
Operating cost
13.81%294.02M
16.19%145.69M
38.56%521.41M
30.85%378.94M
35.70%258.34M
38.61%125.39M
-18.32%376.3M
-8.19%289.61M
-8.71%190.38M
4.67%90.47M
Operating tax surcharges
9.84%3.15M
12.95%1.58M
9.35%5.71M
33.21%4.42M
68.82%2.87M
142.25%1.39M
23.66%5.22M
17.70%3.32M
-11.92%1.7M
-58.52%575.8K
Operating expense
39.50%39.64M
-10.54%14.81M
-8.60%64.07M
-25.16%45.1M
-38.65%28.42M
0.40%16.56M
63.74%70.09M
168.00%60.27M
194.12%46.32M
189.38%16.49M
Administration expense
7.66%55.78M
0.93%28.54M
1.31%116.4M
7.71%83.11M
4.45%51.81M
21.43%28.28M
11.81%114.89M
5.33%77.16M
11.56%49.6M
12.62%23.29M
Financial expense
4.17%18.86M
30.84%11.67M
146.34%24.14M
613.79%24.21M
625.93%18.11M
13.16%8.92M
70.73%9.8M
-161.77%-4.71M
-34.50%2.49M
409.85%7.88M
-Interest expense (Financial expense)
15.17%27.57M
30.15%13.91M
87.36%44.42M
214.91%33.57M
202.32%23.94M
9.58%10.69M
144.54%23.71M
22.10%10.66M
60.50%7.92M
359.48%9.76M
-Interest Income (Financial expense)
5.79%-7.01M
48.52%-1.54M
-703.62%-17.99M
-707.35%-10.4M
-985.37%-7.45M
-126.80%-2.99M
-146.09%-2.24M
-87.32%-1.29M
-37.59%-686.02K
-682.66%-1.32M
Research and development
38.09%142.76M
33.68%65.05M
20.08%248.59M
17.81%163.82M
10.16%103.39M
13.85%48.66M
19.47%207.02M
16.09%139.05M
18.29%93.85M
93.19%42.74M
Credit Impairment Loss
-16.91%-4.42M
-49.71%125.75K
-279.70%-2.47M
-146.30%-6.88M
18.84%-3.78M
119.38%250.04K
113.33%1.37M
60.32%-2.79M
31.54%-4.66M
-317.36%-1.29M
Asset Impairment Loss
35.49%-5.23M
----
-46.70%-21.49M
-13.46%-8.11M
-13.46%-8.11M
----
-55.91%-14.65M
-1,549.30%-7.15M
-2,142.32%-7.15M
----
Other net revenue
Fair value change income
-189.76%-1.56M
-840.99%-2.48M
84.68%-520.01K
109.73%255.43K
-50.95%1.74M
228.34%334.71K
-529.84%-3.39M
-20,533.24%-2.62M
1,031.75%3.55M
-1,799.84%-260.8K
Invest income
-36.98%-6.58M
-192.83%-4.55M
-472.54%-14.74M
-189.46%-8.24M
-146.38%-4.81M
-144.26%-1.55M
-57.14%3.96M
305.80%9.21M
516.90%10.36M
-271.98%-635.56K
-Including: Investment income associates
-5.48%-4.9M
-135.05%-3.41M
-52.58%-13.61M
-63.55%-7.5M
-49.21%-4.65M
---1.45M
3.46%-8.92M
29.55%-4.58M
18.56%-3.11M
----
Asset deal income
----
----
----
----
----
----
57.00%9.89K
--0
----
----
Other revenue
120.71%8.72M
472.38%4.8M
45.12%30.27M
-28.85%5.65M
45.61%3.95M
54.25%838.63K
263.52%20.86M
76.64%7.95M
-36.19%2.71M
10.43%543.67K
Operating profit
-16.86%94.4M
-6.50%70.69M
-21.44%190.24M
-6.72%197.96M
-6.03%113.54M
15.80%75.61M
-6.50%242.16M
6.34%212.21M
1.06%120.83M
18.64%65.29M
Add:Non operating Income
151.43%28.59K
358,861.36%6.32K
-81.06%199.02K
-81.93%194.61K
-98.67%11.37K
-99.99%1.76
882.79%1.05M
1,953.19%1.08M
2,471.72%854.31K
31.00%27.27K
Less:Non operating expense
-57.05%119.57K
--111.08K
67.50%1.67M
-41.68%462.78K
-37.76%278.41K
----
-39.20%999.01K
-49.66%793.53K
-70.67%447.32K
-97.14%15.1K
Total profit
-16.75%94.31M
-6.64%70.59M
-22.06%188.77M
-6.97%197.69M
-6.57%113.28M
15.78%75.61M
-5.92%242.21M
7.30%212.5M
2.68%121.24M
19.77%65.3M
Less:Income tax cost
-18.86%12.08M
-8.20%8.78M
-50.14%15.35M
-39.49%20.95M
-13.13%14.89M
27.50%9.56M
54.70%30.78M
26.98%34.62M
16.22%17.14M
26.52%7.5M
Net profit
-16.43%82.23M
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
-5.49%98.39M
14.26%66.04M
-11.00%211.43M
4.16%177.88M
0.75%104.11M
18.95%57.8M
Net profit from continuing operation
-16.43%82.23M
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
-5.49%98.39M
14.26%66.04M
-11.00%211.43M
4.16%177.88M
0.75%104.11M
18.95%57.8M
Less:Minority Profit
-118.42%-24.14M
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
-39.96%-11.05M
-59.97%-4.72M
-341.03%-28.2M
-224.17%-19.75M
-123.31%-7.9M
-27,242.61%-2.95M
Net profit of parent company owners
-2.81%106.36M
-9.47%64.07M
-15.51%202.47M
-2.95%191.79M
-2.29%109.44M
16.48%70.77M
-1.77%239.62M
11.73%197.62M
4.80%112M
25.00%60.75M
Earning per share
Basic earning per share
-3.85%0.25
-11.76%0.15
-17.24%0.48
-6.25%0.45
-3.70%0.26
13.33%0.17
-3.33%0.58
11.63%0.48
3.85%0.27
25.00%0.15
Diluted earning per share
-3.85%0.25
-11.76%0.15
-17.24%0.48
-6.25%0.45
-3.70%0.26
13.33%0.17
-3.33%0.58
11.63%0.48
3.85%0.27
25.00%0.15
Other composite income
-766.40%-35.14M
-2.29M
22.82%-26.4M
-2,417.43%-4.91M
-548.86%-4.06M
-3,236.33%-34.2M
270.05%211.75K
227.26%903.5K
Other composite income of parent company owners
-766.40%-35.14M
---2.29M
22.82%-26.4M
-2,417.43%-4.91M
-548.86%-4.06M
----
-3,236.33%-34.2M
270.05%211.75K
227.26%903.5K
----
Total composite income
-50.08%47.09M
-9.87%59.52M
-17.04%147.02M
-3.51%171.83M
-10.17%94.33M
14.26%66.04M
-25.07%177.22M
4.36%178.09M
2.33%105.01M
20.06%57.8M
Total composite income of parent company owners
-32.41%71.23M
-12.70%61.78M
-14.29%176.07M
-5.54%186.88M
-6.66%105.38M
16.48%70.77M
-15.44%205.42M
11.93%197.84M
6.36%112.9M
26.17%60.75M
Total composite income of minority owners
-118.42%-24.14M
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
-39.96%-11.05M
-59.97%-4.72M
-341.03%-28.2M
-224.17%-19.75M
-123.31%-7.9M
-27,242.61%-2.95M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 11.95%657.69M11.54%340.13M15.94%1.18B18.46%914.88M17.41%587.48M22.77%304.94M-3.33%1.02B3.19%772.32M4.43%500.35M31.53%248.37M
Operating revenue 11.95%657.69M11.54%340.13M15.94%1.18B18.46%914.88M17.41%587.48M22.77%304.94M-3.33%1.02B3.19%772.32M4.43%500.35M31.53%248.37M
Total operating cost 19.72%554.21M16.64%267.34M25.15%980.32M23.89%699.6M20.45%462.93M26.32%229.2M-0.78%783.33M4.30%564.69M8.62%384.34M35.63%181.44M
Operating cost 13.81%294.02M16.19%145.69M38.56%521.41M30.85%378.94M35.70%258.34M38.61%125.39M-18.32%376.3M-8.19%289.61M-8.71%190.38M4.67%90.47M
Operating tax surcharges 9.84%3.15M12.95%1.58M9.35%5.71M33.21%4.42M68.82%2.87M142.25%1.39M23.66%5.22M17.70%3.32M-11.92%1.7M-58.52%575.8K
Operating expense 39.50%39.64M-10.54%14.81M-8.60%64.07M-25.16%45.1M-38.65%28.42M0.40%16.56M63.74%70.09M168.00%60.27M194.12%46.32M189.38%16.49M
Administration expense 7.66%55.78M0.93%28.54M1.31%116.4M7.71%83.11M4.45%51.81M21.43%28.28M11.81%114.89M5.33%77.16M11.56%49.6M12.62%23.29M
Financial expense 4.17%18.86M30.84%11.67M146.34%24.14M613.79%24.21M625.93%18.11M13.16%8.92M70.73%9.8M-161.77%-4.71M-34.50%2.49M409.85%7.88M
-Interest expense (Financial expense) 15.17%27.57M30.15%13.91M87.36%44.42M214.91%33.57M202.32%23.94M9.58%10.69M144.54%23.71M22.10%10.66M60.50%7.92M359.48%9.76M
-Interest Income (Financial expense) 5.79%-7.01M48.52%-1.54M-703.62%-17.99M-707.35%-10.4M-985.37%-7.45M-126.80%-2.99M-146.09%-2.24M-87.32%-1.29M-37.59%-686.02K-682.66%-1.32M
Research and development 38.09%142.76M33.68%65.05M20.08%248.59M17.81%163.82M10.16%103.39M13.85%48.66M19.47%207.02M16.09%139.05M18.29%93.85M93.19%42.74M
Credit Impairment Loss -16.91%-4.42M-49.71%125.75K-279.70%-2.47M-146.30%-6.88M18.84%-3.78M119.38%250.04K113.33%1.37M60.32%-2.79M31.54%-4.66M-317.36%-1.29M
Asset Impairment Loss 35.49%-5.23M-----46.70%-21.49M-13.46%-8.11M-13.46%-8.11M-----55.91%-14.65M-1,549.30%-7.15M-2,142.32%-7.15M----
Other net revenue
Fair value change income -189.76%-1.56M-840.99%-2.48M84.68%-520.01K109.73%255.43K-50.95%1.74M228.34%334.71K-529.84%-3.39M-20,533.24%-2.62M1,031.75%3.55M-1,799.84%-260.8K
Invest income -36.98%-6.58M-192.83%-4.55M-472.54%-14.74M-189.46%-8.24M-146.38%-4.81M-144.26%-1.55M-57.14%3.96M305.80%9.21M516.90%10.36M-271.98%-635.56K
-Including: Investment income associates -5.48%-4.9M-135.05%-3.41M-52.58%-13.61M-63.55%-7.5M-49.21%-4.65M---1.45M3.46%-8.92M29.55%-4.58M18.56%-3.11M----
Asset deal income ------------------------57.00%9.89K--0--------
Other revenue 120.71%8.72M472.38%4.8M45.12%30.27M-28.85%5.65M45.61%3.95M54.25%838.63K263.52%20.86M76.64%7.95M-36.19%2.71M10.43%543.67K
Operating profit -16.86%94.4M-6.50%70.69M-21.44%190.24M-6.72%197.96M-6.03%113.54M15.80%75.61M-6.50%242.16M6.34%212.21M1.06%120.83M18.64%65.29M
Add:Non operating Income 151.43%28.59K358,861.36%6.32K-81.06%199.02K-81.93%194.61K-98.67%11.37K-99.99%1.76882.79%1.05M1,953.19%1.08M2,471.72%854.31K31.00%27.27K
Less:Non operating expense -57.05%119.57K--111.08K67.50%1.67M-41.68%462.78K-37.76%278.41K-----39.20%999.01K-49.66%793.53K-70.67%447.32K-97.14%15.1K
Total profit -16.75%94.31M-6.64%70.59M-22.06%188.77M-6.97%197.69M-6.57%113.28M15.78%75.61M-5.92%242.21M7.30%212.5M2.68%121.24M19.77%65.3M
Less:Income tax cost -18.86%12.08M-8.20%8.78M-50.14%15.35M-39.49%20.95M-13.13%14.89M27.50%9.56M54.70%30.78M26.98%34.62M16.22%17.14M26.52%7.5M
Net profit -16.43%82.23M-6.41%61.81M-17.97%173.42M-0.64%176.74M-5.49%98.39M14.26%66.04M-11.00%211.43M4.16%177.88M0.75%104.11M18.95%57.8M
Net profit from continuing operation -16.43%82.23M-6.41%61.81M-17.97%173.42M-0.64%176.74M-5.49%98.39M14.26%66.04M-11.00%211.43M4.16%177.88M0.75%104.11M18.95%57.8M
Less:Minority Profit -118.42%-24.14M52.17%-2.26M-3.00%-29.04M23.78%-15.05M-39.96%-11.05M-59.97%-4.72M-341.03%-28.2M-224.17%-19.75M-123.31%-7.9M-27,242.61%-2.95M
Net profit of parent company owners -2.81%106.36M-9.47%64.07M-15.51%202.47M-2.95%191.79M-2.29%109.44M16.48%70.77M-1.77%239.62M11.73%197.62M4.80%112M25.00%60.75M
Earning per share
Basic earning per share -3.85%0.25-11.76%0.15-17.24%0.48-6.25%0.45-3.70%0.2613.33%0.17-3.33%0.5811.63%0.483.85%0.2725.00%0.15
Diluted earning per share -3.85%0.25-11.76%0.15-17.24%0.48-6.25%0.45-3.70%0.2613.33%0.17-3.33%0.5811.63%0.483.85%0.2725.00%0.15
Other composite income -766.40%-35.14M-2.29M22.82%-26.4M-2,417.43%-4.91M-548.86%-4.06M-3,236.33%-34.2M270.05%211.75K227.26%903.5K
Other composite income of parent company owners -766.40%-35.14M---2.29M22.82%-26.4M-2,417.43%-4.91M-548.86%-4.06M-----3,236.33%-34.2M270.05%211.75K227.26%903.5K----
Total composite income -50.08%47.09M-9.87%59.52M-17.04%147.02M-3.51%171.83M-10.17%94.33M14.26%66.04M-25.07%177.22M4.36%178.09M2.33%105.01M20.06%57.8M
Total composite income of parent company owners -32.41%71.23M-12.70%61.78M-14.29%176.07M-5.54%186.88M-6.66%105.38M16.48%70.77M-15.44%205.42M11.93%197.84M6.36%112.9M26.17%60.75M
Total composite income of minority owners -118.42%-24.14M52.17%-2.26M-3.00%-29.04M23.78%-15.05M-39.96%-11.05M-59.97%-4.72M-341.03%-28.2M-224.17%-19.75M-123.31%-7.9M-27,242.61%-2.95M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Notarized Tianye Certified Public Accountants (Special General Partnership)------Notarized Tianye Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg